GLP-1 agonists associated with lower stroke risk in patients with type 2 diabetes at high risk for cardiovascular disease

There's more to see -- the rest of this topic is available only to subscribers.

All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.